Malaria screening unsuccessful in some schools

January 28, 2014

School-based intermittent screening and treatment programs for malaria may be unsuccessful in low to moderate transmission areas

A school-based intermittent screening and treatment program for malaria in rural coastal Kenya had no benefits on the health and education of school children, according to a study by international researchers published in this week's PLOS Medicine.

The study, led by Katherine Halliday and Simon Brooker from the London School of Hygiene & Tropical Medicine, included over 5000 children from 101 government schools. Half of the schools were randomized to receive the intermittent screening and treatment programme--screening once a school term for malaria parasites using a rapid diagnostic test followed by treatment with the anti-malarial drug artemether-lumefantrine for all children who tested positive for malaria parasitaemia (whether symptomatic or asymptomatic) .

During the intervention period, almost 90% of children in classes 1 and 5 of the intervention schools were screened at each round, of whom 17.5% tested RDT-positive for malaria. However, the authors found that there was no difference at 12 and 24 months between the proportion of children with anemia and the proportion of children who tested positive for malaria parasites in the intervention and control groups. And at 9 and 24 months, there was also no difference in class attention scores between the two groups.

The authors say: "In contrast to the beneficial impact of previous school-based malaria control our findings show there are no health or education benefits of implementing school-based intermittent screening and treatment programs with artemether-lumefantrine in a low to moderate transmission setting such as this study site."

The authors add: "Nevertheless, our results do highlight a potential role for schools as screening platforms whereby pockets of high transmission can be identified for targeted malaria control"

In an accompanying Perspective, Lorenz von Seidlein, from the Menzies School of Health Research in Casuarina, Australia, discusses the reasons that the program was unsuccessful and the wider issues involved in failure of screening and treating as a malaria elimination strategy. He suggests: "After other approaches have failed perhaps an evaluation of strategies based on presumptive treatment of targeted populations should now have the highest priority?"
-end-
Research Article

Funding: This work was supported by grants from the International Initiative for Impact Evaluation, the Partnership for Child Development, and the Development Impact Evaluation Initiative as part of the Malaria Impact Evaluation Program of the World Bank. GO is supported by a Wellcome Trust Masters Training Fellowship (092765) and SJB is supported by a Wellcome Trust Senior Fellowship in Basic Biomedical Science (098045). The funders had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.

Competing Interests: The authors have declared that no competing interests exist.

Citation: Halliday KE, Okello G, Turner EL, Njagi K, Mcharo C, et al. (2014) Impact of Intermittent Screening and Treatment for Malaria among School Children in Kenya: A Cluster Randomised Trial. PLoS Med 11(1): e1001594. doi:10.1371/journal.pmed.1001594

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:

http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001594

Contact:

Katherine Elizabeth Halliday
London School of Hygiene & Tropical Medicine
UNITED KINGDOM
+44 (0)207 958 8238
katherine.halliday@lshtm.ac.uk

Perspective Article

Funding: No funding was received for any aspect of the writing of this Perspective.

Competing Interests: The author declares that he has no competing interests.

Citation: von Seidlein L (2014) The Failure of Screening and Treating as a Malaria Elimination Strategy. PLoS Med 11(1): e1001595. doi:10.1371/journal.pmed.1001595

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:

http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001595

Contact:

Lorenz von Seidlein
Mahidol-Oxford Tropical Medicine Research Unit
THAILAND
+66 (0)2-3549170
Lorenz@tropmedres.ac

PLOS

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.